leadf
logo-loader
viewe-Therapeutics PLC

ETX surges on positive clinical data and appointment of Steve Medlicott

Steve Medlicott, the newly-appointed CFO of e-Therapeutics (LON:ETX) tells Proactive Investors the company has sufficient funds to support its development in the four years to come.

Quick facts: e-Therapeutics PLC

Price: 12.625 GBX

AIM:ETX
Market: AIM
Market Cap: £53.12 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics PLC named herein, including the promotion by the Company of e-Therapeutics PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

2 min read